Clinical trial
PD1 and PARP for Maintenance Therapy in NSLLC
NCT05392686
Study timeline
Study start (estimated)2022-06-20Date precision: day
Registry last updated2022-05-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
PD-1 inhibitorDRUG
PARP inhibitorDRUG
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05392686 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.